BUSINESS
Urjit Patel's resignation 'leaves RBI's reputation in tatters': Ex-FM Chidambaram
Chidambaram said he was saddened, not surprised, by Dr Urjit Patel's resignation.
BUSINESS
India pharma market slows due to lower offtake of anti-infective, respiratory drugs
Anti-infectives sales grew 3.8 percent in November compared to 13.6 percent in October. Respiratory segment sales dropped to 2.6 percent compared to 14.7 percent in the same period
BUSINESS
Pharma weekly blog: Family power struggles and fist fights
The first generation entrepreneur builds the enterprise, but things get complex at succession due to palace intrigues and infighting among family members
BUSINESS
No immediate job cuts at GSKCH, but concerns remain after HUL buy
"These are complicated deals. They don't close overnight. We will not leave our people in the lurch as we have to run the business for next several quarters," said a person with knowledge of the matter
BUSINESS
Shivinder Singh calls brother Malvinder's accusation of assault 'a false & shameless attempt'
Shivinder said the gulf between our value systems is clearly too wide and the latest incident closes all options for any possible solution to work together.
BUSINESS
Chennai-based MGM Healthcare to set up South India-focused hospital chain
MGM expects the two upcoming hospitals in Chennai to take its bed capacity to 1000 in the next two years.
BUSINESS
Corporate governance overhang haunts Sun Pharma despite management rebuttal
Sun Pharma has been trying to restore investor confidence, after a scathing note by Australian brokerage firm Macquarie and a whistleblower complaint to the Securities and Exchange of India (SEBI) last week, the drug maker stock since then dropped one-fifth of its value.
BUSINESS
Why GSK had to sell its Indian consumer health business
Under the leadership of Emma Walmsley, who was elevated as CEO of GSK in April 2017, the company is focusing on three long-term priorities “Innovation, Performance and Trust.”
BUSINESS
Ready to evaluate structures and transactions to assuage investor concerns: Sun Pharma
"As of now, the company has not received any query from SEBI with regards to whistleblower complaint, Sun Pharma founder and MD Dilip Shanghvi said.
BUSINESS
Why Sun Pharma finds itself in an unusual situation
Shares of India's largest drug maker dropped around 6.46 percent in the last five trading days.
BUSINESS
Patients with faulty J&J hip implants may get up to Rs 1.22-crore compensation
There are currently no specific legal provisions in India to provide compensation to patients
BUSINESS
Medical devices sector faces credibility test as evidence points to irregularities
Earlier this week the International Consortium of International Journalists (ICIJ) and a team of more than 250 reporters and data specialists from 58 news organizations in 36 countries, including the Indian Express have filtered hundreds of cases to investigate various aspects of the medical device industry — regulation, faulty devices and corruption.
BUSINESS
From electrical hardware to digitilisation provider, here’s how Siemens is reinventing itself
Digitalisation involves deploying a network of tools like software, sensors, camera and actuators to capture every possible data point on the shop floor seamlessly
BUSINESS
Sun Pharma settles Modafinil antitrust litigation with certain US plaintiffs
A group of direct purchasers sued Cephalon, Mylan, Teva and Ranbaxy Laboratories in 2006 for so-called “pay-for-delay” settlements in which brand-name drug makers pay their generic counterparts to keep drugs off the market.
BUSINESS
French consumable maker Peters Surgical plans to make India hub of manufacturing and R&D
Peters Surgical global CEO Thierry Herbreteau said the company is actively on the lookout for acquisitions.
BUSINESS
US appeals court allows Dr Reddy's Labs to sell generic Suboxone
Dr Reddy's had booked sales of around $10-15 million days after its launch before it was stayed by the court.
BUSINESS
Cipla faces heat due to lower offtake of HIV drugs in tender market
Cipla’s management in its recent investor call indicated that the global tender business sales could be lower by $100-120m in FY19 led by funding crunch and competition.
BUSINESS
Govt appoints Rajasthan bureaucrat Shubhra Singh as NPPA Chairman
Singh has pro-industry credentials, she was Joint Secretary, Department of Industrial Policy & Promotion (DIPP) under Ministry of Commerce and Industry, Government of India betweeb 2014 and 2015.
BUSINESS
Global Fund policies impacting fight against AIDS, tuberculosis and malaria
The Global Fund raises and invests nearly $4 billion a year to support programmes run by local experts in countries and communities most in need
BUSINESS
Armed with clinical trial data, Indian stent makers prepare to challenge MNC domination
India made cardiac stents which were often dismissed globally including by a section of our own doctors as inferior and not proven for safety and efficacy, are finally breaking that mould.
BUSINESS
Medical devices maker Trivitron Healthcare plans IPO in 2 years
The company has set a revenue target of Rs 1000 crore in next two years, and plans to commercialise a new born screening solution in US.
BUSINESS
Apollo Hospitals to hive off pharmacy business into separate entity
The proposed move helps Apollo to become compliant with the the prescribed foreign direct investment (FDI) limits and further grow the pharmacy retail business.
BUSINESS
IHH assumes control of Fortis, latter’s board approves Rs 4,000cr preferential allotment
IHH said the mandatory open offer for acquiring up to 26 percent stake from existing shareholders of Fortis would be completed in due course
BUSINESS
Aurobindo Pharma beats Q2 profit estimates, buys inhalation assets from Australian firm
The net profit was helped by depreciating rupee against dollar and euro in its key US and Europe markets, that constitute nearly three-fourths of sales.
